Johnson Chemical Pharmaceutical Works Co., Ltd.(TW:4747)
NT$15.80-1.75 (-9.97%)
TW:4747
Johnson Chemical Pharmaceutical Works Co., Ltd. financials statements
NT$15.80
At close:-1.75 (-9.97%)
Johnson Chemical Pharmaceutical Works Co., Ltd. (4747) Income Statement
Johnson Chemical Pharmaceutical Works Co., Ltd. Income Statement
Last quarter (Q2 2026), Johnson Chemical Pharmaceutical Works Co., Ltd.'s total revenue was NT$146.54M, an increase of 6.04% from the same quarter last year. In Q2, Johnson Chemical Pharmaceutical Works Co., Ltd.'s net income was NT$10.44M. See Johnson Chemical Pharmaceutical Works Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 569.77M | NT$ 611.41M | NT$ 606.71M | NT$ 494.67M | NT$ 411.49M | |
| NT$ 228.35M | NT$ 247.97M | NT$ 244.63M | NT$ 204.38M | NT$ 171.92M | |
| NT$ 155.01M | NT$ 149.97M | NT$ 145.80M | NT$ 121.70M | NT$ 109.64M | |
| Depreciation and Amortization | NT$ 20.34M | NT$ 20.97M | NT$ 21.11M | NT$ 18.27M | NT$ 15.29M |
| NT$ 93.67M | NT$ 133.19M | NT$ 126.59M | NT$ 101.74M | NT$ 78.30M | |
| NT$ 73.33M | NT$ 98.00M | NT$ 98.83M | NT$ 83.47M | NT$ 63.02M | |
| NT$ -9.96M | NT$ 10.51M | NT$ 2.06M | NT$ -1.14M | NT$ -346.00K | |
| NT$ 63.38M | NT$ 108.71M | NT$ 100.89M | NT$ 81.53M | NT$ 61.94M | |
| NT$ 53.51M | NT$ 84.12M | NT$ 79.70M | NT$ 64.85M | NT$ 49.10M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 0.59 | NT$ 0.94 | NT$ 1.12 | NT$ 1.08 | NT$ 0.74 |
| Diluted EPS | NT$ 0.59 | NT$ 0.93 | NT$ 1.05 | NT$ 1.08 | NT$ 0.74 |
| Weighted Average Shares Outstanding | 89.92M | 90.19M | 71.16M | 66.23M | 66.23M |
| Weighted Average Shares Outstanding (Diluted) | 89.92M | 93.09M | 75.96M | 66.37M | 66.42M |
Currency in TWD
